Package 62856-212-01

Brand: leqembi

Generic: lecanemab
NDC Package

Package Facts

Identity

Package NDC 62856-212-01
Digits Only 6285621201
Product NDC 62856-212
Product ID 62856-212_81ef20f0-d4f7-4f69-b081-e297224b653f
Description

1 VIAL, SINGLE-DOSE in 1 CARTON (62856-212-01) / 2 mL in 1 VIAL, SINGLE-DOSE

Marketing

Marketing Status
Marketed Since 2023-01-06
Brand leqembi
Generic lecanemab
Sample Package No

Linked Drug Pages (1)

LEQEMBI, LECANEMAB AUTOINJECTOR ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "81ef20f0-d4f7-4f69-b081-e297224b653f", "openfda": {"nui": ["N0000193951", "N0000193950"], "unii": ["12PYH0FTU9"], "rxcui": ["2626147", "2626153", "2626155", "2626156", "2723406"], "spl_set_id": ["9d1ff786-e577-410a-a273-c4d7d0e4e975"], "pharm_class_epc": ["Amyloid Beta-directed Antibody [EPC]"], "pharm_class_moa": ["Amyloid Beta-directed Antibody Interactions [MoA]"], "manufacturer_name": ["Eisai Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (62856-212-01)  / 2 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "62856-212-01", "marketing_start_date": "20230106"}], "brand_name": "LEQEMBI", "product_id": "62856-212_81ef20f0-d4f7-4f69-b081-e297224b653f", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Amyloid Beta-directed Antibody Interactions [MoA]", "Amyloid Beta-directed Antibody [EPC]"], "product_ndc": "62856-212", "generic_name": "lecanemab", "labeler_name": "Eisai Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "LEQEMBI", "active_ingredients": [{"name": "LECANEMAB", "strength": "100 mg/mL"}], "application_number": "BLA761269", "marketing_category": "BLA", "marketing_start_date": "20230106", "listing_expiration_date": "20271231"}